Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

1.

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations.

Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, Engel C, Nogues C, Buecher B, Mari V, Moretta-Serra J, Gladieff L, Luporsi E, Barrowdale D, Frost D, Henderson A, Brewer C, Evans DG, Eccles D, Cook J, Ong KR, Izatt L, Ahmed M, Morrison PJ, Dommering CJ, Oosterwijk JC, Ausems MGEM, Kriege M, Buys SS, Andrulis IL, John EM, Daly M, Friedlander M, McLachlan SA, Osorio A, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Arver B, Olsson H, Schmutzler RK, Hopper JL, van Leeuwen FE, Goldgar D, Milne RL, Easton DF, Rookus MA, Andrieu N; EMBRACE, GENEPSO, BCFR, HEBON, kConFab and IBCCS.

JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.

2.

10-year performance of four models of breast cancer risk: a validation study.

Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S, Andrulis IL, John EM, Phillips KA, Daly MB, Buys SS, Hopper JL, MacInnis RJ.

Lancet Oncol. 2019 Feb 21. pii: S1470-2045(18)30902-1. doi: 10.1016/S1470-2045(18)30902-1. [Epub ahead of print]

PMID:
30799262
3.

Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape.

Philip J, Collins A, Ritchie D, Le B, Millar J, McLachlan SA, Krishnasamy M, Hudson P, Sundararajan V.

Leuk Lymphoma. 2019 Feb 7:1-9. doi: 10.1080/10428194.2018.1564047. [Epub ahead of print]

PMID:
30732498
4.

Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.

Zeinomar N, Phillips KA, Daly MB, Milne RL, Dite GS, MacInnis RJ, Liao Y, Kehm RD, Knight JA, Southey MC, Chung WK, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S; kConFab Investigators, Andrulis IL, Buys SS, John EM, Hopper JL, Terry MB.

Int J Cancer. 2019 Feb 6. doi: 10.1002/ijc.32112. [Epub ahead of print]

PMID:
30725480
5.

Ferritin levels throughout childhood and metabolic syndrome in adolescent stage.

Suárez-Ortegón MF, Blanco E, McLachlan S, Fernandez-Real JM, Burrows R, Wild SH, Lozoff B, Gahagan S.

Nutr Metab Cardiovasc Dis. 2019 Mar;29(3):268-278. doi: 10.1016/j.numecd.2018.11.008. Epub 2018 Dec 4.

PMID:
30648600
6.

To reflect human autoimmune thyroiditis, thyroid peroxidase (not thyroglobulin) antibodies should be measured in female (not sex-independent) NOD.H2h4 mice.

McLachlan SM, Aliesky HA, Rapoport B.

Clin Exp Immunol. 2019 Apr;196(1):52-58. doi: 10.1111/cei.13249. Epub 2019 Jan 11.

PMID:
30566234
7.

GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes.

Franceschini N, Giambartolomei C, de Vries PS, Finan C, Bis JC, Huntley RP, Lovering RC, Tajuddin SM, Winkler TW, Graff M, Kavousi M, Dale C, Smith AV, Hofer E, van Leeuwen EM, Nolte IM, Lu L, Scholz M, Sargurupremraj M, Pitkänen N, Franzén O, Joshi PK, Noordam R, Marioni RE, Hwang SJ, Musani SK, Schminke U, Palmas W, Isaacs A, Correa A, Zonderman AB, Hofman A, Teumer A, Cox AJ, Uitterlinden AG, Wong A, Smit AJ, Newman AB, Britton A, Ruusalepp A, Sennblad B, Hedblad B, Pasaniuc B, Penninx BW, Langefeld CD, Wassel CL, Tzourio C, Fava C, Baldassarre D, O'Leary DH, Teupser D, Kuh D, Tremoli E, Mannarino E, Grossi E, Boerwinkle E, Schadt EE, Ingelsson E, Veglia F, Rivadeneira F, Beutner F, Chauhan G, Heiss G, Snieder H, Campbell H, Völzke H, Markus HS, Deary IJ, Jukema JW, de Graaf J, Price J, Pott J, Hopewell JC, Liang J, Thiery J, Engmann J, Gertow K, Rice K, Taylor KD, Dhana K, Kiemeney LALM, Lind L, Raffield LM, Launer LJ, Holdt LM, Dörr M, Dichgans M, Traylor M, Sitzer M, Kumari M, Kivimaki M, Nalls MA, Melander O, Raitakari O, Franco OH, Rueda-Ochoa OL, Roussos P, Whincup PH, Amouyel P, Giral P, Anugu P, Wong Q, Malik R, Rauramaa R, Burkhardt R, Hardy R, Schmidt R, de Mutsert R, Morris RW, Strawbridge RJ, Wannamethee SG, Hägg S, Shah S, McLachlan S, Trompet S, Seshadri S, Kurl S, Heckbert SR, Ring S, Harris TB, Lehtimäki T, Galesloot TE, Shah T, de Faire U, Plagnol V, Rosamond WD, Post W, Zhu X, Zhang X, Guo X, Saba Y; MEGASTROKE Consortium, Dehghan A, Seldenrijk A, Morrison AC, Hamsten A, Psaty BM, van Duijn CM, Lawlor DA, Mook-Kanamori DO, Bowden DW, Schmidt H, Wilson JF, Wilson JG, Rotter JI, Wardlaw JM, Deanfield J, Halcox J, Lyytikäinen LP, Loeffler M, Evans MK, Debette S, Humphries SE, Völker U, Gudnason V, Hingorani AD, Björkegren JLM, Casas JP, O'Donnell CJ.

Nat Commun. 2018 Dec 3;9(1):5141. doi: 10.1038/s41467-018-07340-5.

8.

The effect of rehabilitation interventions on physical function and immobility-related complications in severe stroke-protocol for a systematic review.

McGlinchey MP, James J, McKevitt C, Douiri A, McLachlan S, Sackley CM.

Syst Rev. 2018 Nov 17;7(1):197. doi: 10.1186/s13643-018-0870-y.

9.

The Heimdall Framework for Supporting Characterisation of Learning Health Systems.

McLachlan S, Potts HWW, Dube K, Buchanan D, Lean S, Gallagher T, Johnson O, Daley B, Marsh W, Fenton N.

J Innov Health Inform. 2018 Jun 15;25(2):77-87. doi: 10.14236/jhi.v25i2.996.

10.

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC).

Hopper JL, Dite GS, MacInnis RJ, Liao Y, Zeinomar N, Knight JA, Southey MC, Milne RL, Chung WK, Giles GG, Genkinger JM, McLachlan SA, Friedlander ML, Antoniou AC, Weideman PC, Glendon G, Nesci S; kConFab Investigators, Andrulis IL, Buys SS, Daly MB, John EM, Phillips KA, Terry MB.

Breast Cancer Res. 2018 Nov 3;20(1):132. doi: 10.1186/s13058-018-1056-1.

11.

The trajectory of patients who die from metastatic prostate cancer: a population-based study.

Collins A, Sundararajan V, Millar J, Burchell J, Le B, Krishnasamy M, McLachlan SA, Hudson P, Mileshkin L, Philip J.

BJU Int. 2018 Oct 29. doi: 10.1111/bju.14593. [Epub ahead of print]

PMID:
30371986
12.

Reflections on Thyroid Autoimmunity: A Personal Overview from the Past into the Future.

Rapoport B, McLachlan SM.

Horm Metab Res. 2018 Dec;50(12):840-852. doi: 10.1055/a-0725-9297. Epub 2018 Oct 24. Review.

PMID:
30357776
13.

Thyroid Hemiagenesis in a Thyroiditis Prone Mouse Strain.

McLachlan SM, Aliesky HA, Garcia P, Banuelos B, Rapoport B.

Eur Thyroid J. 2018 Aug;7(4):187-192. doi: 10.1159/000490700. Epub 2018 Jul 18.

14.

Correction: Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.

Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, Lin HJ, McLachlan S, Bokemark L, Ronkainen K, Amato M, Schminke U, Srinivasan SR, Lind L, Okazaki S, Stehouwer CDA, Willeit P, Polak JF, Steinmetz H, Sander D, Poppert H, Desvarieux M, Ikram MA, Johnsen SH, Staub D, Sirtori CR, Iglseder B, Beloqui O, Engström G, Friera A, Rozza F, Xie W, Parraga G, Grigore L, Plichart M, Blankenberg S, Su TC, Schmidt C, Tuomainen TP, Veglia F, Völzke H, Nijpels G, Willeit J, Sacco RL, Franco OH, Uthoff H, Hedblad B, Suarez C, Izzo R, Zhao D, Wannarong T, Catapano A, Ducimetiere P, Espinola-Klein C, Chien KL, Price JF, Bergström G, Kauhanen J, Tremoli E, Dörr M, Berenson G, Kitagawa K, Dekker JM, Kiechl S, Sitzer M, Bickel H, Rundek T, Hofman A, Mathiesen EB, Castelnuovo S, Landecho MF, Rosvall M, Gabriel R, de Luca N, Liu J, Baldassarre D, Kavousi M, de Groot E, Bots ML, Yanez DN, Thompson SG; PROG-IMT study group.

PLoS One. 2018 Sep 20;13(9):e0204633. doi: 10.1371/journal.pone.0204633. eCollection 2018.

15.

Systematic reviews and tech mining: A methodological comparison with case study.

Anderson PF, Shannon C, Bickett S, Doucette J, Herring P, Kepsel A, Lyons T, McLachlan S, Wu L.

Res Synth Methods. 2018 Dec;9(4):540-550. doi: 10.1002/jrsm.1318. Epub 2018 Sep 21.

PMID:
30129708
16.

'Pretty fit and healthy': The discussion of older people in cancer multidisciplinary meetings.

Lane HP, McLachlan S, Philip JAM.

J Geriatr Oncol. 2019 Jan;10(1):84-88. doi: 10.1016/j.jgo.2018.06.001. Epub 2018 Jun 20.

PMID:
29936076
17.

Ferritin, metabolic syndrome and its components: A systematic review and meta-analysis.

Suárez-Ortegón MF, Ensaldo-Carrasco E, Shi T, McLachlan S, Fernández-Real JM, Wild SH.

Atherosclerosis. 2018 Aug;275:97-106. doi: 10.1016/j.atherosclerosis.2018.05.043. Epub 2018 May 23.

PMID:
29886355
18.

The extent, quality and impact of patient and public involvement in primary care research: a mixed methods study.

Blackburn S, McLachlan S, Jowett S, Kinghorn P, Gill P, Higginbottom A, Rhodes C, Stevenson F, Jinks C.

Res Involv Engagem. 2018 May 24;4:16. doi: 10.1186/s40900-018-0100-8. eCollection 2018.

19.

Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Chen CR, McLachlan SM, Hubbard PA, McNally R, Murali R, Rapoport B.

Thyroid. 2018 Jul;28(7):933-940. doi: 10.1089/thy.2018.0176. Epub 2018 Jun 29.

PMID:
29845889
20.

Learning Health Systems: The research community awareness challenge.

McLachlan S, Dube K, Buchanan D, Lean S, Johnson O, Potts H, Gallagher T, Marsh W, Fenton N.

J Innov Health Inform. 2018 Mar 27;25(1):981. doi: 10.14236/jhi.v25i1.981. No abstract available.

21.

Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.

Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, Lin HJ, McLachlan S, Bokemark L, Ronkainen K, Amato M, Schminke U, Srinivasan SR, Lind L, Okazaki S, Stehouwer CDA, Willeit P, Polak JF, Steinmetz H, Sander D, Poppert H, Desvarieux M, Ikram MA, Johnsen SH, Staub D, Sirtori CR, Iglseder B, Beloqui O, Engström G, Friera A, Rozza F, Xie W, Parraga G, Grigore L, Plichart M, Blankenberg S, Su TC, Schmidt C, Tuomainen TP, Veglia F, Völzke H, Nijpels G, Willeit J, Sacco RL, Franco OH, Uthoff H, Hedblad B, Suarez C, Izzo R, Zhao D, Wannarong T, Catapano A, Ducimetiere P, Espinola-Klein C, Chien KL, Price JF, Bergström G, Kauhanen J, Tremoli E, Dörr M, Berenson G, Kitagawa K, Dekker JM, Kiechl S, Sitzer M, Bickel H, Rundek T, Hofman A, Mathiesen EB, Castelnuovo S, Landecho MF, Rosvall M, Gabriel R, de Luca N, Liu J, Baldassarre D, Kavousi M, de Groot E, Bots ML, Yanez DN, Thompson SG; PROG-IMT study group.

PLoS One. 2018 Apr 12;13(4):e0191172. doi: 10.1371/journal.pone.0191172. eCollection 2018. Erratum in: PLoS One. 2018 Sep 20;13(9):e0204633.

22.

Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.

Suárez-Ortegón MF, McLachlan S, Price AH, Fernández-Balsells M, Franch-Nadal J, Mata-Cases M, Barrot-de la Puente J, Mundet-Tudurí X, Mauricio D, Ricart W, Wild SH, Strachan MWJ, Price JF, Fernández-Real JM.

Atherosclerosis. 2018 May;272:193-199. doi: 10.1016/j.atherosclerosis.2018.03.028. Epub 2018 Mar 21.

PMID:
29625295
23.

A Role for Satb1 in Thyroid Autoimmunity?

McLachlan SM, Rapoport B.

Thyroid. 2018 May;28(5):682-683. doi: 10.1089/thy.2017.0713. Epub 2018 Apr 5. No abstract available.

PMID:
29620973
24.

Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer.

Collins A, Sundararajan V, Burchell J, Millar J, McLachlan SA, Krishnasamy M, Le BH, Mileshkin L, Hudson P, Philip J.

J Pain Symptom Manage. 2018 Aug;56(2):185-194. doi: 10.1016/j.jpainsymman.2018.03.022. Epub 2018 Mar 30.

PMID:
29608934
25.

Aberrant Iodine Autoregulation Induces Hypothyroidism in a Mouse Strain in the Absence of Thyroid Autoimmunity.

McLachlan SM, Aliesky HA, Rapoport B.

J Endocr Soc. 2017 Nov 29;2(1):63-76. doi: 10.1210/js.2017-00400. eCollection 2018 Jan 1.

26.

Thyroid Autoantibodies Display both "Original Antigenic Sin" and Epitope Spreading.

McLachlan SM, Rapoport B.

Front Immunol. 2017 Dec 20;8:1845. doi: 10.3389/fimmu.2017.01845. eCollection 2017. Review.

27.

How should we talk about palliative care, death and dying? A qualitative study exploring perspectives from caregivers of people with advanced cancer.

Collins A, McLachlan SA, Philip J.

Palliat Med. 2018 Apr;32(4):861-869. doi: 10.1177/0269216317746584. Epub 2017 Dec 13.

PMID:
29235421
28.

Maaqwi cascadensis: A large, marine diving bird (Avialae: Ornithurae) from the Upper Cretaceous of British Columbia, Canada.

McLachlan SMS, Kaiser GW, Longrich NR.

PLoS One. 2017 Dec 8;12(12):e0189473. doi: 10.1371/journal.pone.0189473. eCollection 2017.

29.

Communication about palliative care: A phenomenological study exploring patient views and responses to its discussion.

Collins A, McLachlan SA, Philip J.

Palliat Med. 2018 Jan;32(1):133-142. doi: 10.1177/0269216317735247. Epub 2017 Nov 13.

PMID:
29130425
30.

Long-term survivors of glioblastoma: a closer look.

Gately L, McLachlan SA, Philip J, Ruben J, Dowling A.

J Neurooncol. 2018 Jan;136(1):155-162. doi: 10.1007/s11060-017-2635-1. Epub 2017 Oct 27.

PMID:
29079955
31.

Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record.

Walonoski J, Kramer M, Nichols J, Quina A, Moesel C, Hall D, Duffett C, Dube K, Gallagher T, McLachlan S.

J Am Med Inform Assoc. 2017 Aug 30. doi: 10.1093/jamia/ocx079. [Epub ahead of print]

PMID:
29025144
32.

Variable Effects of Dietary Selenium in Mice That Spontaneously Develop a Spectrum of Thyroid Autoantibodies.

McLachlan SM, Aliesky H, Banuelos B, Hee SSQ, Rapoport B.

Endocrinology. 2017 Nov 1;158(11):3754-3764. doi: 10.1210/en.2017-00275.

33.

EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.

Clay TD, Russell PA, Do H, Sundararajan V, Conron M, Wright GM, Solomon B, Dobrovic A, McLachlan SA, Moore MM.

Med Oncol. 2017 Sep 6;34(10):175. doi: 10.1007/s12032-017-1031-1.

PMID:
28879441
34.

Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.

Lee YC, Milne RL, Lheureux S, Friedlander M, McLachlan SA, Martin KL, Bernardini MQ, Smith C, Picken S, Nesci S, Hopper JL, Phillips KA; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).

Eur J Cancer. 2017 Oct;84:114-120. doi: 10.1016/j.ejca.2017.07.004. Epub 2017 Aug 10.

PMID:
28802188
35.

Hamp1 mRNA and plasma hepcidin levels are influenced by sex and strain but do not predict tissue iron levels in inbred mice.

McLachlan S, Page KE, Lee SM, Loguinov A, Valore E, Hui ST, Jung G, Zhou J, Lusis AJ, Fuqua B, Ganz T, Nemeth E, Vulpe CD.

Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G511-G523. doi: 10.1152/ajpgi.00307.2016. Epub 2017 Aug 10.

36.

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.

Price AH, Weir CJ, Welsh P, McLachlan S, Strachan MWJ, Sattar N, Price JF.

Atherosclerosis. 2017 Sep;264:67-73. doi: 10.1016/j.atherosclerosis.2017.07.009. Epub 2017 Jul 12.

37.

Fear of Cancer Recurrence in an Era of Personalized Medicine.

Thewes B, Husson O, Poort H, Custers JAE, Butow PN, McLachlan SA, Prins JB.

J Clin Oncol. 2017 Oct 10;35(29):3275-3278. doi: 10.1200/JCO.2017.72.8212. Epub 2017 Jul 19. No abstract available.

PMID:
28723231
38.

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC; BRCA1 and BRCA2 Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H.

JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.

PMID:
28632866
39.

Mechanisms of Autoantibody-Induced Pathology.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F.

Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Review.

40.

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Jenks SJ, Conway BR, McLachlan S, Teoh WL, Williamson RM, Webb DJ, Welsh P, Sattar N, Strachan MWJ, Price JF.

Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.

41.

Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.

Dale CE, Fatemifar G, Palmer TM, White J, Prieto-Merino D, Zabaneh D, Engmann JEL, Shah T, Wong A, Warren HR, McLachlan S, Trompet S, Moldovan M, Morris RW, Sofat R, Kumari M, Hyppönen E, Jefferis BJ, Gaunt TR, Ben-Shlomo Y, Zhou A, Gentry-Maharaj A, Ryan A; UCLEB Consortium; METASTROKE Consortium, Mutsert R, Noordam R, Caulfield MJ, Jukema JW, Worrall BB, Munroe PB, Menon U, Power C, Kuh D, Lawlor DA, Humphries SE, Mook-Kanamori DO, Sattar N, Kivimaki M, Price JF, Davey Smith G, Dudbridge F, Hingorani AD, Holmes MV, Casas JP.

Circulation. 2017 Jun 13;135(24):2373-2388. doi: 10.1161/CIRCULATIONAHA.116.026560. Epub 2017 May 12.

42.

Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.

Fairoozy RH, Cooper J, White J, Giambartolomei C, Folkersen L, Wannamethee SG, Jefferis BJ, Whincup P, Ben-Shlomo Y, Kumari M, Kivimaki M, Wong A, Hardy R, Kuh D, Gaunt TR, Casas JP, McLachlan S, Price JF, Hingorani A, Franco-Cereceda A, Grewal T, Kalea AZ, Humphries SE; UCLEB consortium.

Atherosclerosis. 2017 Jun;261:60-68. doi: 10.1016/j.atherosclerosis.2017.04.010. Epub 2017 Apr 13.

43.

Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report.

Tanaka T, Slavin J, McLachlan SA, Choong P.

Oncol Lett. 2017 Apr;13(4):2105-2108. doi: 10.3892/ol.2017.5693. Epub 2017 Feb 8.

44.

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J.

Support Care Cancer. 2017 Oct;25(10):3171-3179. doi: 10.1007/s00520-017-3725-5. Epub 2017 Apr 22.

PMID:
28434095
45.

Initial perceptions of palliative care: An exploratory qualitative study of patients with advanced cancer and their family caregivers.

Collins A, McLachlan SA, Philip J.

Palliat Med. 2017 Oct;31(9):825-832. doi: 10.1177/0269216317696420. Epub 2017 Apr 3.

PMID:
28367679
46.

Genes Outside the Major Histocompatibility Complex Locus Are Linked to the Development of Thyroid Autoantibodies and Thyroiditis in NOD.H2h4 Mice.

McLachlan SM, Lesage S, Collin R, Banuelos B, Aliesky HA, Rapoport B.

Endocrinology. 2017 Apr 1;158(4):702-713. doi: 10.1210/en.2016-1875.

47.

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.

Lee YC, Bressel M, Grant P, Russell P, Smith C, Picken S, Camm S, Kiely BE, Milne RL, McLachlan SA, Hickey M, Friedlander ML, Hopper JL, Phillips KA; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).

Fam Cancer. 2017 Oct;16(4):461-469. doi: 10.1007/s10689-017-9977-x.

48.

Life beyond a diagnosis of glioblastoma: a systematic review of the literature.

Gately L, McLachlan SA, Dowling A, Philip J.

J Cancer Surviv. 2017 Aug;11(4):447-452. doi: 10.1007/s11764-017-0602-7. Epub 2017 Feb 13. Review.

PMID:
28194640
49.

High-level intrathymic thyrotrophin receptor expression in thyroiditis-prone mice protects against the spontaneous generation of pathogenic thyrotrophin receptor autoantibodies.

McLachlan SM, Aliesky HA, Banuelos B, Lesage S, Collin R, Rapoport B.

Clin Exp Immunol. 2017 May;188(2):243-253. doi: 10.1111/cei.12928. Epub 2017 Feb 20.

50.

Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.

Rapoport B, Banuelos B, Aliesky HA, Hartwig Trier N, McLachlan SM.

J Immunol. 2016 Dec 15;197(12):4560-4568. Epub 2016 Nov 9.

Supplemental Content

Loading ...
Support Center